Amanote Research

Amanote Research

    RegisterSign In

Glibenclamide Therapy in Diabetes Mellitus

BMJ
doi 10.1136/bmj.2.5709.570
Full Text
Open PDF
Abstract

Available in full text

Date

June 6, 1970

Authors
S. K. BhatiaD. R. HaddenD. A. D. MontgomeryJ. A. Weaver
Publisher

BMJ


Related search

Combined Therapy of Diabetes Mellitus

BMJ
1963English

Pharmacoeconomic Analysis of the Use of a Fixed Dose Combination of Metformin and Glibenclamide in the Therapy of Diabetes Mellitus Type 2

Pharmacoeconomics: theory and practice
2016English

Stem Cell Therapy in Diabetes Mellitus: Current Trends

International Journal of Biomedical Research
2012English

What Drives Thrombogenesis Despite Antiplatelet Therapy in Diabetes Mellitus?

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2010English

Antioxidants (Alpha-Tocoferol Acetate) in Therapy of Diabetes Mellitus

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1993English

Prospects of Antigen-Specific Therapy in Type 1 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Diabetes (Diabetes Mellitus)

2019English

Combined Therapy in Dyslipidemia and Hyperglicemia of Diabetes Mellitus Type II

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy